Gilead Sciences, Inc.
Pyrrolo[1,2-B]pyridazine derivatives

Last updated:

Abstract:

A compound of Formula (I): ##STR00001## pharmaceutically acceptable salts thereof, deuterated analogs thereof, compositions thereof, and methods of treating disease using a compound thereof, wherein the variable substituents are disclosed herein.

Status:
Grant
Type:

Utility

Filling date:

11 Jul 2019

Issue date:

29 Dec 2020